Jubilant gets rights to produce Gilead Remdesivir, a potential therapy for Covid-19 in 127 countries including India
Jubilant Generics Limited (Jubilant), has entered into a non-exclusive Licensing Agreement with Gilead Sciences, Inc. that will grant Jubilant the ...